Video Experimental Relacionado

Updated: Jan 8, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

Liberación de las Alarminas de las Vías Respiratorias IL-33 y TSLP en el Asma Aguda Grave Pediátrica: Un Estudio de

M Ramphul¹, I C Scott², H Killick²

¹Department of Paediatric Respiratory Medicine, Leicester Children's Hospital. Leicester Royal Infirmary, Leicester, UK.

Acta paediatrica (Oslo, Norway : 1992)

|December 12, 2025

Abstracto

Aim:

Interleukin (IL)-33 and thymic stromal lymphopoietin (TSLP) released in the airways are believed to be associated with a greater risk of childhood-onset asthma. The aim of this study was to measure the release of IL-33 and TSLP into the airways of children and young people (CYP) during asthma attacks and compare these alarmin-cytokine levels with stable disease patients and non-asthmatic controls.

Methods:

We conducted a prospective observational case-control feasibility study, where we measured the levels of IL-33 and TSLP using high sensitivity immunoassays in the airways of children and young people (CYP) during asthma attacks, stable disease patients and non-asthmatic control individuals.

Results:

Median concentrations of sputum IL-33 and TSLP from acute asthmatics were 3.4 and 17.7 times higher, respectively, in acute asthmatics compared to stable asthmatic children. Sputum IL-33 and TSLP were not different in the stable asthma group compared to non-asthmatic controls.

Conclusion:

IL-33 and TSLP were significantly elevated during acute severe asthma attacks and could potentially drive further airway inflammation and remodelling during asthma attacks in children. Results support further clinical evaluation of anti-TSLP and anti-IL-33 biologic therapeutics for preventing or reducing the frequency of asthma attacks in children.

Palabras clave:

IL-33 TSLP epitelio de las vías respiratorias alarmina asma biomarcador exacerbación pediátrico fenotipado

Más Videos Relacionados

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

Videos de Conceptos Relacionados

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Breathing

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...